Louisiana State Employees Retirement System Acquires Shares of 92,400 Hims & Hers Health, Inc. (NYSE:HIMS)

Louisiana State Employees Retirement System acquired a new stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 92,400 shares of the company's stock, valued at approximately $2,234,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HIMS. Crewe Advisors LLC purchased a new position in Hims & Hers Health in the 4th quarter valued at $28,000. Raleigh Capital Management Inc. boosted its position in shares of Hims & Hers Health by 1,100.0% during the 4th quarter. Raleigh Capital Management Inc. now owns 1,200 shares of the company's stock worth $29,000 after purchasing an additional 1,100 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of Hims & Hers Health by 2,173.7% during the 4th quarter. GAMMA Investing LLC now owns 2,251 shares of the company's stock worth $54,000 after purchasing an additional 2,152 shares in the last quarter. Quest Partners LLC boosted its position in shares of Hims & Hers Health by 22.6% during the 3rd quarter. Quest Partners LLC now owns 4,373 shares of the company's stock worth $81,000 after purchasing an additional 807 shares in the last quarter. Finally, CWM LLC boosted its position in shares of Hims & Hers Health by 21.4% during the 3rd quarter. CWM LLC now owns 5,982 shares of the company's stock worth $110,000 after purchasing an additional 1,054 shares in the last quarter. 63.52% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HIMS has been the topic of several research analyst reports. Bank of America lowered shares of Hims & Hers Health from a "buy" rating to an "underperform" rating and decreased their target price for the stock from $32.00 to $18.00 in a research report on Thursday, November 14th. Canaccord Genuity Group boosted their price objective on shares of Hims & Hers Health from $28.00 to $38.00 and gave the stock a "buy" rating in a research report on Monday, December 2nd. TD Cowen reiterated a "buy" rating and issued a $28.00 price objective on shares of Hims & Hers Health in a research report on Wednesday, November 20th. Morgan Stanley lowered shares of Hims & Hers Health from an "overweight" rating to an "equal weight" rating and upped their target price for the company from $42.00 to $60.00 in a report on Tuesday. Finally, BTIG Research initiated coverage on shares of Hims & Hers Health in a report on Tuesday, January 7th. They issued a "buy" rating and a $35.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $26.33.

Insider Transactions at Hims & Hers Health

In related news, insider Michael Chi sold 2,054 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $33.56, for a total transaction of $68,932.24. Following the completion of the sale, the insider now owns 184,947 shares of the company's stock, valued at approximately $6,206,821.32. This represents a 1.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Andrew Dudum sold 33,513 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $33.38, for a total transaction of $1,118,663.94. Following the sale, the chief executive officer now directly owns 33,502 shares of the company's stock, valued at approximately $1,118,296.76. This trade represents a 50.01 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,052,332 shares of company stock worth $32,620,497 in the last three months. Company insiders own 17.71% of the company's stock.

Hims & Hers Health Stock Down 1.3 %

Shares of HIMS stock traded down $0.76 during trading hours on Tuesday, hitting $59.71. 13,030,238 shares of the company were exchanged, compared to its average volume of 13,641,217. The firm has a market cap of $13.05 billion, a PE ratio of 135.71 and a beta of 1.35. Hims & Hers Health, Inc. has a 1 year low of $9.22 and a 1 year high of $64.84. The firm has a fifty day moving average of $32.61 and a 200 day moving average of $24.60.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.